Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis

被引:0
作者
Didier Lebrec
Jaime Bosch
Rajiv Jalan
Francis J. Dudley
Rada Jessic
Richard Moreau
Juan Carlos Garcia-Pagan
Rajeshwar P. Mookerjee
Eleonora Chiossi
Paul L. M. Van Giersbergen
Andjela Kusic-Pajic
Jasper Dingemanse
机构
[1] INSERM,Unité 773, Centre de Recherche Biomédicale Bichat
[2] Hôpital Beaujon,Beaujon CRB3
[3] Liver Unit Hospital IDIBAP and Ciberehd,Service d’Hépatologie
[4] University College London Medical School,Hepatic Hemodynamic Laboratory
[5] Alfred Hospital and Baker Research Institute,Institute of Hepatology
[6] Clinic for Gastroenterology and Hepatology,Institute for Digestive Diseases
[7] Clinical Development,undefined
[8] Actelion Pharmaceuticals Ltd,undefined
来源
European Journal of Clinical Pharmacology | 2012年 / 68卷
关键词
Tezosentan; Endothelin receptor antagonist; Cirrhosis; Portal hypertension; Pharmacokinetics; Pharmacodynamics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:533 / 541
页数:8
相关论文
共 128 条
[1]  
Iwakiri Y(2008)Vascular biology and pathobiology of the liver: report of a single-topic symposium Hepatology 47 1754-1763
[2]  
Grisham M(1997)The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide Hepatology 25 2-5
[3]  
Shah V(1988)A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 411-415
[4]  
Rockey D(1992)Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome N Engl J Med 327 1774-1778
[5]  
Yanagisawa M(1992)Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis Hepatology 16 95-99
[6]  
Kurihara H(1994)Relations entre les concentrations plasmatiques d’endotheline et la severite de la cirrhose Gastroenterol Clin Biol 18 407-412
[7]  
Kimura Y(1995)Increased plasma endothelin in cirrhosis. Relationship with systemic endotoxemia and response to changes in effective blood volume J Hepatol 22 389-398
[8]  
Tomobe Y(1995)Endothelin-1 and endothelin-3 in cirrhosis: relations to systemic and splanchnic haemodynamics J Hepatol 23 135-144
[9]  
Kobayashi M(1996)Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems J Hepatol 24 161-168
[10]  
Mitsui Y(1998)Beneficial hemodynamic effects of bosentan, a mixed ET Hepatology 28 655-659